Epidermal growth factor/transforming growth factor alpha receptors and psoriasis
- PMID: 16788618
- DOI: 10.1111/1523-1747.ep12505661
Epidermal growth factor/transforming growth factor alpha receptors and psoriasis
Abstract
The abnormal growth and differentiation in psoriasis is reflected in the abnormal regulation of Epidermal Growth Factor/Transforming Growth Factor Alpha (EGF/TGFalpha) receptor metabolism. In psoriasis and other hyperproliferative skin conditions these receptors are persistently expressed throughout the interfollicular epidermis as long as the growth stimulatory signal persists. One of the first biochemical signs of effective therapy of psoriasis is the return of the EGF/TGFalpha receptor pattern toward the primarily basilar distribution seen in normal human adult skin. Whether the abnormal expression of TGFalpha in the involved skin induces the persistent expression of EGF receptors is not known nor is the signal that causes the increased production of TGFalpha. Studies to determine what factors regulate EGF receptor expression and TGFalpha induction may yield important new insights into the pathogenesis and therapy of psoriasis.
Similar articles
-
The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.Arch Dermatol Res. 2008 Jan;300(1):37-45. doi: 10.1007/s00403-007-0809-y. Epub 2007 Oct 25. Arch Dermatol Res. 2008. PMID: 17960400
-
Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes.Arch Dermatol Res. 2003 Jul;295(3):93-101. doi: 10.1007/s00403-003-0391-x. Epub 2003 May 27. Arch Dermatol Res. 2003. PMID: 12768307
-
Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis.J Invest Dermatol. 1986 Mar;86(3):260-5. doi: 10.1111/1523-1747.ep12285389. J Invest Dermatol. 1986. PMID: 3018088
-
Transforming growth factor alpha.Cell Biol Int. 1995 May;19(5):373-88. doi: 10.1006/cbir.1995.1083. Cell Biol Int. 1995. PMID: 7640654 Review.
-
Growth factor and proto-oncogene expression in psoriasis.J Invest Dermatol. 1990 Nov;95(5 Suppl):7S-9S. doi: 10.1111/1523-1747.ep12505653. J Invest Dermatol. 1990. PMID: 16788617 Review.
Cited by
-
EGF-Induced Macropinocytosis Promotes NAV1-Dependent Internalization of Occludin in Keratinocytes.FASEB J. 2025 Apr 30;39(8):e70564. doi: 10.1096/fj.202402876R. FASEB J. 2025. PMID: 40266031 Free PMC article.
-
Aloe polysaccharide promotes keratinocyte proliferation, migration, and differentiation by upregulating the EGFR/PKC-dependent signaling pathways.Sci Rep. 2025 Mar 10;15(1):8196. doi: 10.1038/s41598-025-91201-x. Sci Rep. 2025. PMID: 40064981 Free PMC article.
-
Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype.J Clin Invest. 1997 Nov 1;100(9):2286-94. doi: 10.1172/JCI119766. J Clin Invest. 1997. PMID: 9410906 Free PMC article.
-
Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits.Dermatol Ther (Heidelb). 2021 Aug;11(4):1157-1174. doi: 10.1007/s13555-021-00560-6. Epub 2021 Jun 9. Dermatol Ther (Heidelb). 2021. PMID: 34106439 Free PMC article. Review.
-
Regulation of Bcl-xL expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor.Proc Natl Acad Sci U S A. 1997 May 13;94(10):5067-72. doi: 10.1073/pnas.94.10.5067. Proc Natl Acad Sci U S A. 1997. PMID: 9144191 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical